Smiths Group PLC
SWB:QS2A
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Smiths Group PLC
SWB:QS2A
|
UK |
|
ABC Arbitrage SA
F:9BA
|
FR |
|
Tissue Regenix Group PLC
LSE:TRX
|
UK |
|
C
|
CSG Systems International Inc
XMUN:CSN
|
US |
Wall St Price Targets
QS2A Price Targets Summary
Smiths Group PLC
According to Wall Street analysts, the average 1-year price target for
QS2A is 32.07 EUR with a low forecast of 27.05 EUR and a high forecast of 37.05 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is QS2A's stock price target?
Price Target
32.07
EUR
According to Wall Street analysts, the average 1-year price target for
QS2A is 32.07 EUR with a low forecast of 27.05 EUR and a high forecast of 37.05 EUR.
What is the Revenue forecast for Smiths Group PLC?
Projected CAGR
-8%
Over the last 13 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 3 years is -8%.
What is the Gross Profit forecast for Smiths Group PLC?
Projected CAGR
-7%
Over the last 13 years, the compound annual growth rate for Gross Profit has been -2%. The projected CAGR for the next 3 years is -7%.
What is the Operating Income forecast for Smiths Group PLC?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Operating Income has been 1%. The projected CAGR for the next 3 years is 7%.
What is the Pre-Tax Income forecast for Smiths Group PLC?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 0%. The projected CAGR for the next 3 years is 9%.
What is the Net Income forecast for Smiths Group PLC?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 3 years is 12%.